FFCP PHASE1:Hg19::chr16:75511082..75511090,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C224 | |||
|description=CAGE_peak_at_chr16:75511082..75511090,+ | |||
|id=chr16:75511082..75511090,+ | |||
|ontology_enrichment_celltype=CL:0000313!2.58e-34!1;CL:0002149!6.07e-23!6;CL:0002255!6.07e-23!6;CL:0000159!6.48e-18!2 | |||
|ontology_enrichment_celltype_v019=CL:0000313;2.39e-66;1!CL:0000159;5.04e-34;2!CL:0002149;2.74e-12;6!CL:0002255;2.74e-12;6 | |||
|ontology_enrichment_celltype_v019_2=CL:0000313,2.39e-66,1;CL:0000159,5.04e-34,2;CL:0002149,2.74e-12,6;CL:0002255,2.74e-12,6 | |||
|ontology_enrichment_development_v019=UBERON:0009117;6.13e-08;10!UBERON:0005564;6.13e-08;10!UBERON:0005795;6.56e-08;10 | |||
|ontology_enrichment_disease=DOID:2152!2.58e-34!1;DOID:3001!6.07e-23!6;DOID:299!9.78e-22!25;DOID:120!3.53e-20!27;DOID:193!7.78e-19!29;DOID:4468!5.48e-18!2 | |||
|ontology_enrichment_disease_v019=DOID:2152;2.39e-66;1!DOID:4468;3.61e-34;2!DOID:299;1.10e-24;25!DOID:120;5.98e-23;27!DOID:193;1.88e-21;29!DOID:3001;2.74e-12;6 | |||
|ontology_enrichment_disease_v019_2=DOID:2152,2.39e-66,1;DOID:4468,3.61e-34,2;DOID:299,1.10e-24,25;DOID:120,5.98e-23,27;DOID:193,1.88e-21,29;DOID:3001,2.74e-12,6 | |||
|ontology_enrichment_uberon=UBERON:0004911!2.58e-34!1;UBERON:0004909!6.48e-18!2;UBERON:0003134!7.63e-15!37;UBERON:0000474!7.63e-15!37;UBERON:0003100!1.86e-13!41;UBERON:0001896!3.24e-12!3;UBERON:0005290!3.24e-12!3;UBERON:0010096!3.24e-12!3;UBERON:0003133!1.40e-11!48;UBERON:0000992!3.56e-11!13;UBERON:0005156!1.59e-09!59;UBERON:0000990!1.59e-09!59;UBERON:0000995!2.77e-07!21;UBERON:0000991!2.77e-07!21;UBERON:0009196!2.77e-07!21;UBERON:0009117!2.77e-07!21;UBERON:0005564!2.77e-07!21;UBERON:0005795!5.40e-07!22;UBERON:0003975!5.40e-07!22;UBERON:0004176!5.40e-07!22 | |||
|ontology_enrichment_uberon_v019=UBERON:0004911;2.39e-66;1!UBERON:0004909;5.04e-34;2!UBERON:0000474;2.91e-09;37!UBERON:0003134;1.30e-08;33!UBERON:0003133;4.60e-07;44 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0004911,2.39e-66,1;UBERON:0004909,5.04e-34,2;UBERON:0003134,3.03e-08,37;UBERON:0000474,3.03e-08,37;UBERON:0003100,1.52e-07,41 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.4278889713421,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.56203764501618,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.110929051536852,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.150420656698515,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.22910686854405,0,0,2.9082412267426,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr16:75511082..75511090,+ | |||
}} |
Revision as of 12:18, 20 January 2014
Short description: | p@chr16:75511082..75511090, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr16:75511082..75511090, + |
Coexpression cluster: | C224_clear_serous_pleomorphic_choriocarcinoma_mesothelioma_amniotic_renal |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
serous secreting cell | 2.39e-66 | 1 |
seromucus secreting cell | 5.04e-34 | 2 |
epithelial cell of uterus | 2.74e-12 | 6 |
stromal cell of endometrium | 2.74e-12 | 6 |
Ontology term | p-value | n |
---|---|---|
epithelium of female gonad | 2.39e-66 | 1 |
epithelium of gonad | 5.04e-34 | 2 |
female reproductive organ | 3.03e-08 | 37 |
female reproductive system | 3.03e-08 | 37 |
female organism | 1.52e-07 | 41 |
Ontology term | p-value | n |
---|---|---|
ovary epithelial cancer | 2.39e-66 | 1 |
clear cell adenocarcinoma | 3.61e-34 | 2 |
adenocarcinoma | 1.10e-24 | 25 |
female reproductive organ cancer | 5.98e-23 | 27 |
reproductive organ cancer | 1.88e-21 | 29 |
female reproductive endometrioid cancer | 2.74e-12 | 6 |